HALEH STRATTON: Open Payments
NPI 1710125745 · SUWANEE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,038 in 92 payments from 19 companies in 2025. Trend: 2023 $1,971 · 2024 $1,646 · 2025 $2,038
Food & beverage: $2,038
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 23 | $468 |
| Novartis Pharmaceuticals Corporation | 13 | $281 |
| Arcutis Biotherapeutics, Inc. | 17 | $210 |
| GENZYME CORPORATION | 3 | $194 |
| Regeneron Healthcare Solutions, Inc. | 6 | $180 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $111 |
| Lilly USA, LLC | 3 | $86 |
| ABBVIE INC. | 4 | $80 |
| PFIZER INC. | 3 | $70 |
| UCB, Inc. | 2 | $62 |
Products named: OPZELURA, DUPIXENT, COSENTYX, Zoryve, Winlevi, TALTZ, Bimzelx, SKYRIZI.
Industry payments across GA — which companies pay providers there.
